EP1276751A4 - Neue nukleinsäuren und polypeptide - Google Patents

Neue nukleinsäuren und polypeptide

Info

Publication number
EP1276751A4
EP1276751A4 EP01912764A EP01912764A EP1276751A4 EP 1276751 A4 EP1276751 A4 EP 1276751A4 EP 01912764 A EP01912764 A EP 01912764A EP 01912764 A EP01912764 A EP 01912764A EP 1276751 A4 EP1276751 A4 EP 1276751A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
new nucleic
new
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01912764A
Other languages
English (en)
French (fr)
Other versions
EP1276751A2 (de
Inventor
Y Tom Tang
Chenghua Liu
Ping Zhou
Vinod Asundi
Jie Zhang
Qing A Zhao
Feiyan Ren
Aidong J Xue
Yonghong Yang
Tom Wehrman
Jian-Rui Wang
Yunqing Ma
Dunrui Wang
Rui-Hong Chen
Chongjun Xu
Radoje Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1276751A2 publication Critical patent/EP1276751A2/de
Publication of EP1276751A4 publication Critical patent/EP1276751A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP01912764A 2000-02-28 2001-02-26 Neue nukleinsäuren und polypeptide Withdrawn EP1276751A4 (de)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US515126 1983-07-19
US664641 1984-10-25
US51512600A 2000-02-28 2000-02-28
US57740900A 2000-05-18 2000-05-18
US577409 2000-05-18
US59770700A 2000-06-17 2000-06-17
US597707 2000-06-17
US61680700A 2000-07-14 2000-07-14
US616807 2000-07-14
US66464100A 2000-09-19 2000-09-19
PCT/US2001/004926 WO2001064834A2 (en) 2000-02-28 2001-02-26 Novel nucleic acids and polypeptides

Publications (2)

Publication Number Publication Date
EP1276751A2 EP1276751A2 (de) 2003-01-22
EP1276751A4 true EP1276751A4 (de) 2005-04-06

Family

ID=27541818

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01912764A Withdrawn EP1276751A4 (de) 2000-02-28 2001-02-26 Neue nukleinsäuren und polypeptide

Country Status (4)

Country Link
EP (1) EP1276751A4 (de)
AU (1) AU2001241511A1 (de)
CA (1) CA2401505A1 (de)
WO (1) WO2001064834A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6706262B1 (en) 1998-03-18 2004-03-16 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
EP1196562A4 (de) * 1999-06-29 2007-01-10 Autogen Res Pty Ltd NEUE GENE UND DEREN VERWENDUNG IN DER MODULIERUNG VON FETTLEIBIGKEIT, DIABETES UND ENERGIEGLEICHGEWICHTSSTöRUNG
CA2401438C (fr) * 2000-02-29 2011-11-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) Nouvelle proteine ulip/crmp humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques
US7235649B2 (en) 2000-03-24 2007-06-26 Duke University Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same
CA2429196A1 (en) 2000-03-24 2001-10-04 Duke University Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
AU2001264715A1 (en) * 2000-05-19 2001-12-03 Millennium Pharmaceuticals, Inc. 55158, a novel human carbonic anhydrase and uses thereof
US20040210042A1 (en) * 2001-07-19 2004-10-21 Tsuchida Jun-Ichi Polypeptides relating to signal transfer of advanced glycation end product receptor
WO2003027279A1 (en) 2001-09-25 2003-04-03 Sony Corporation p300 HISTONE ACETYLASE INHIBITOR
AU2002356959A1 (en) * 2001-11-16 2003-06-10 Incyte Genomics, Inc. Organelle-associated proteins
AU2002365517A1 (en) * 2001-11-26 2003-06-10 Hybrigenics Protein-protein interactions involving transforming growth factor beta signalling
AU2003219085A1 (en) * 2002-03-20 2003-09-29 Novartis Ag Methods for diagnosing and treating schizophrenia
GB0217033D0 (en) * 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
US20080145928A1 (en) 2002-07-25 2008-06-19 Shuki Mizutani Factor Taking Part in Transcription Control
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
WO2004090113A2 (en) * 2003-03-31 2004-10-21 Seattle Genetics, Inc. L53, a lung cancer associated antigen and uses thereof
WO2005097204A1 (ja) * 2004-04-09 2005-10-20 Takeda Pharmaceutical Company Limited 癌の予防・治療剤
EP1846041A4 (de) * 2004-10-29 2008-05-07 Univ Rochester Modifizierte bakteriophagen-vektoren und ihre verwendungen
CA2616525C (en) * 2005-07-26 2014-06-17 Cms Peptides Patent Holding Company Limited Novel biologically active peptides and their new uses
WO2014134084A2 (en) * 2013-02-26 2014-09-04 Rongfu Wang Phf20 and jmjd3 compositions and methods of use in cancer immunotherapy
EP3609577B1 (de) * 2017-04-14 2024-09-11 University of Massachusetts Braune fettselektive adipokine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831052A (en) * 1997-05-07 1998-11-03 Incyte Pharmaceuticals, Inc. New human translocation associated protein
WO2001049728A2 (en) * 2000-01-06 2001-07-12 Protegene Inc. HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
EP1130094A2 (de) * 1999-07-08 2001-09-05 Helix Research Institute Primer zur Synthese von vollständigen cDNA Klonen und ihre Verwendung

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831052A (en) * 1997-05-07 1998-11-03 Incyte Pharmaceuticals, Inc. New human translocation associated protein
EP1130094A2 (de) * 1999-07-08 2001-09-05 Helix Research Institute Primer zur Synthese von vollständigen cDNA Klonen und ihre Verwendung
WO2001049728A2 (en) * 2000-01-06 2001-07-12 Protegene Inc. HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL EMBL; 17 March 1999 (1999-03-17), XP002303786, retrieved from EBI accession no. EMBL:AI472339 Database accession no. AI472339 *

Also Published As

Publication number Publication date
WO2001064834A8 (en) 2002-02-14
EP1276751A2 (de) 2003-01-22
WO2001064834A2 (en) 2001-09-07
AU2001241511A1 (en) 2001-09-12
CA2401505A1 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
EP1325120A4 (de) Neue nukleinsäuren und polypeptide
EP1341804A4 (de) Neue nukleinsäuren und polypeptide
EP1504099A4 (de) Neue nukleinsäuren und polypeptide
EP1432800A4 (de) Neue nukleinsäuren und polypeptide
EP1242443A4 (de) Neue nukleinsäuren und polypeptide
EP1556490A4 (de) Neue nukleinsäuren und polypeptide
EP1276751A4 (de) Neue nukleinsäuren und polypeptide
EP1368475A4 (de) Neue nukleinsäuren und polypeptide
ATE554171T1 (de) Rezeptor-nukleinsäuren und -polypeptide
AU2001234944A8 (en) Novel nucleic acids and polypeptides
EP1483386A4 (de) Neue nukleinsäuren und abgesonderte polypeptide
EP1341803A4 (de) Neue nukleinsäuren und polypeptide
EP1254266A4 (de) Methoden und materialien in bezug auf alpha-2-makroglobulin ähnliche polypeptide und polynukleotide
EP1282635A4 (de) Neue nukleinsäuren und polypeptide
EP1268762A4 (de) Neue nukleinsäuren und polypeptide
EP1131350A4 (de) Egf-ähnliche nukleinsäuren und polypeptide und deren anwendungen
EP1370675A4 (de) Neue nukleinsäuren und polypeptide
DE60028365D1 (de) Chimäre nukleinsäuren und polypeptide aus lyssavirus
AU7005801A (en) Gp354 nucleic acids and polypeptides
DE60217711D1 (de) Ptp10d nukleinsäuren und peptide in der regulation von energie-homeostase
AU7298201A (en) Gp286 nucleic acids and polypeptides
ATE270675T1 (de) Pro243 polypeptide und dafür kodierende nukleinsäuren
DE60044849D1 (de) Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren
DE60043951D1 (de) Ausgeschiedene Polypeptide und Transmembranpolypeptide und dafür kodierende Nukleinsäuren
ATE459645T1 (de) Ausgeschiedene polypeptide und transmembranpolypeptide und dafür kodierende nukleinsäuren

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020926

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20050217

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20060314